Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02611557 · ClinicalTrials.gov registry record · NA
Lymphedema Progression Screening Using MRI
A NA study, sponsored by Vanderbilt University.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT02611557 is a NA study that has completed, run by Vanderbilt University. The registered enrollment target is 90 participants.
The verdict
NCT02611557, a NA study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
This study will apply novel, noninvasive structural and functional magnetic resonance imaging (MRI) methods to patients with mild and moderate breast cancer-related lymphedema (BCRL) for the first time to test fundamental hypotheses about relationships between lymphatic compromise and imaging biomarkers that may portend disease progression and individualized therapy response.
Interventions
- PROCEDURE Manual lymphatic drainage therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2015-02 |
| Est. Completion | 2019-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02611557
The ClinicalTrials.gov registry entry for NCT02611557 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Manual lymphatic drainage therapy is the first listed.
NCT02611557 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02611557 about?
NCT02611557 is a clinical study titled "Lymphedema Progression Screening Using MRI". This study will apply novel, noninvasive structural and functional magnetic resonance imaging (MRI) methods to patients with mild and moderate breast cancer-related lymphedema (BCRL) for the first time to test fundamental hypotheses about relationships between lymphatic compromise and imaging biomar...
What is the current status of trial NCT02611557?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2015-02. Estimated completion is 2019-06.
What interventions are being tested in trial NCT02611557?
The interventions under investigation include: Manual lymphatic drainage therapy (PROCEDURE).
Who is sponsoring clinical trial NCT02611557?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.